Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Nerve stimulation may ease sexual dysfunction and back Pain—Trial puts it to the test

NCT ID NCT07764445

Disease control Sponsor: Cairo University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 14, 2026 · Last updated Aug 14, 2026

Summary

This trial tests whether transcutaneous tibial nerve stimulation (TTNS), a non-invasive nerve stimulation technique, can improve sexual function and pelvic alignment in women aged 25–35 who have both low back pain and female sexual dysfunction. Participants will receive TTNS alongside pelvic floor (Kegel) exercises, and researchers will measure changes in sexual function, pelvic tilt, lumbar curve, spinal mobility, and pelvic floor muscle activity. The goal is to see if adding TTNS offers benefits beyond exercises alone.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Transcutaneous tibial nerve stimulation (TTNS) plus pelvic floor (Kegel) exercises
What this could lead to
If effective, this approach could offer a non-invasive, drug-free option to improve sexual function and pelvic alignment in women with both low back pain and sexual dysfunction.
What could go wrong
This is a small, early-stage trial with only 40 participants, so results may not apply broadly. The treatment may not outperform standard pelvic floor exercises, and individual responses can vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

25 to 35 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Females are diagnosed with low back pain combined with female sexual dysfunction. * Their ages will be ranged from 25 to 35 years. * Their body mass index (BMI) will be ranged from 23-28 kg/m2. * Patients with a number of normal deliveries ≤ three times * They had regular menstruation. Exclusion Criteria: * Prior history of disc prolapse and sacroiliac joints, symphysis pubic joint as well as lower limb problems. * Genital prolapse. * Leg length discrepancy. * Urinary tract infection. * Diastasis recti, diabetes, intrauterine device. * Surgery related to the spine, abdomen or pelvis as well as skin disease that interferes with the usage of TTNS.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Female sexual dysfunction (FSD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

physiological sexual disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Female sexual dysfunction (FSD)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Cairo university

    Cairo, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.